World's Best Scientists 2026 revealed!
Justin A. Ezekowitz

Justin A. Ezekowitz

D-Index & Metrics

Medicine

D-Index
92
Citations
77011
World Ranking
11054
National Ranking
442

Justin A. Ezekowitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Justin A. Ezekowitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 612 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Justin A. Ezekowitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Justin A. Ezekowitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Justin A. Ezekowitz is affiliated with the University of Alberta in Canada and has a significant body of work primarily in the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine. Their research encompasses a broad range of topics related to heart failure, cardiovascular risk factors, and the treatment and management of diabetes and related metabolic conditions.

Their main fields of study include:

  • Medicine

The subfields of study where Justin A. Ezekowitz has contributed extensively are:

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Pulmonary and Respiratory Medicine
  • Economics and Econometrics
  • Hematology

Key topics covered in their research include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Diabetes Treatment and Management
  • Potassium and Related Disorders
  • Cardiac Arrhythmias and Treatments
  • Health Systems, Economic Evaluations, Quality of Life

Justin A. Ezekowitz has published in a variety of significant venues. The journals where their research appears most frequently are:

  • Journal of the American College of Cardiology
  • Journal of Cardiac Failure
  • Canadian Journal of Cardiology
  • JACC Heart Failure
  • European Journal of Heart Failure

Among the recent papers associated with their work are:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction, 2020, New England Journal of Medicine
  • Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity, 2023, New England Journal of Medicine
  • Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes, 2024, New England Journal of Medicine
  • CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction, 2021, Canadian Journal of Cardiology

The scientist frequently collaborates with several researchers who appear repeatedly as co-authors. These include:

  • Javed Butler
  • Piotr Ponikowski
  • Carolyn S.P. Lam
  • Adriaan A. Voors
  • Adrian F. Hernandez

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • HFSA 2010 Comprehensive Heart Failure Practice Guideline.

    Lindenfeld J;Albert Nm;Boehmer Jp

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.

    Justin A. Ezekowitz;Finlay A. McAlister;Paul W. Armstrong

  • Vericiguat in Patients With Heart Failure and Reduced Ejection Fraction

    Paul W Armstrong;Burkert Pieske;Kevin J Anstrom;Justin Ezekowitz

  • Renal Insufficiency and Heart Failure Prognostic and Therapeutic Implications From a Prospective Cohort Study

    Finlay A. McAlister;Justin Ezekowitz;Marcello Tonelli;Paul W. Armstrong

  • Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.

    Finlay A. McAlister;Justin Ezekowitz;Nicola Hooton;Ben Vandermeer

  • Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

    Finlay A McAlister;Natasha Wiebe;Justin A Ezekowitz;Alexander A Leung

  • 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.

    Justin A. Ezekowitz;Eileen O'Meara;Michael A. McDonald;Howard Abrams

  • Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.

    G. Michael Felker;Kevin J. Anstrom;Kirkwood F. Adams;Justin A. Ezekowitz

  • Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure

    Finlay A. McAlister;Justin A. Ezekowitz;Natasha Wiebe;Brian Rowe

  • The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

    Justin Ezekowitz;Finlay A. McAlister;Karin H. Humphries;Colleen M. Norris

  • The Effects of Climate Change on Cardiac Health.

    Jonathan De Blois;Tord Kjellstrom;Stefan Agewall;Justin A. Ezekowitz

  • Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.

    Justin A. Ezekowitz;Padma Kaul;Jeffery A. Bakal;Paul W. Armstrong

  • Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

    Edith Pituskin;John R Mackey;Sheri Koshman;Davinder Jassal

  • Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

    Justin A. Ezekowitz;Paul W. Armstrong;Finlay A. McAlister

  • Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

    John R. Teerlink;John R. Teerlink;G. Michael Felker;John J. V. McMurray;Scott D. Solomon

  • N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

    Ziyad Hijazi;Lars Wallentin;Agneta Siegbahn;Ulrika Andersson

  • The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial

    Roopinder K. Sandhu;Justin Ezekowitz;Ulrika Andersson;John H. Alexander

Frequent Co-Authors

Paul W. Armstrong
Paul W. Armstrong University of Alberta
Finlay A. McAlister
Finlay A. McAlister University of Alberta
Adrian F. Hernandez
Adrian F. Hernandez Duke University
Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Randall C. Starling
Randall C. Starling Cleveland Clinic
John J.V. McMurray
John J.V. McMurray University of Glasgow
G. Michael Felker
G. Michael Felker Duke University
Robert M. Califf
Robert M. Califf Duke University
Marco Metra
Marco Metra University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens the door to numerous specialized fields. If you’re interested in food science and well-being, an online nutritionist degree can prepare you for jobs in dietetics, public health, or corporate wellness. This pathway enables you to study core human nutrition topics while benefiting from the flexibility of remote learning.

Healthcare management is another growing area, and online mha programs cahme accredited are highly respected for training future healthcare leaders. These programs are designed for working professionals who want to advance into administrative or executive roles within hospitals and healthcare systems.

For registered nurses looking to advance their credentials quickly, there are rn to bsn no clinical hours programs, letting RNs earn a bachelor’s degree with maximum flexibility and minimal disruption to their work schedule.

Doctorate-level nurses may consider short dnp programs to further their expertise and leadership opportunities in clinical practice or administration. These programs are tailored for fast-tracked career advancement and are available entirely online.

Best Scientists Citing Justin A. Ezekowitz

Trending Scientists

Recently Published Articles